OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
July 02, 2019
It is important to adhere to current methods of endotoxin testing, on which the industry relies for process sustainability.
June 19, 2019
Experts from AbbVie discuss the advantages and limitations of HME for enhancing bioavailability of poorly soluble APIs.
June 02, 2019
With an increased focus on the supply chain security of non-cGMP intermediates, companies need to re-emphasize upstream manufacturing.
Big Pharma is partnering with Alphabet company, Verily, to modernize clinical trials and accelerate time-to-market for drugs.
Proactive approaches that consider long-term supply chain security compliance are recommended to ensure companies stay on the right track.
Exploration of various formulation techniques is vital to provide effective delivery of poorly soluble drugs.